WASHINGTON — The US Food and Drug Administration (FDA) on Wednesday authorized using a so-called “mix and match” strategy for people who require a booster shot of a Covid vaccine after their primary series.
ADVERTISEMENT
“The FDA has determined that the known and potential benefits of the use of a single heterologous booster dose outweigh the known and potential risks of their use in eligible populations,” the agency said in a statement.
The Pfizer, Moderna, and Johnson & Johnson vaccines are authorized in the United States. A single dose of any of them may now be used following completion of primary vaccination with a different Covid vaccine.FEATURED STORIES
NEWSINFO
Roque bares Sara Duterte’s last-minute appeal for him to run for Senate
NEWSINFO
‘Saving’ Manila Bay: Dolomite beach, wetlands drowning in wastes
NEWSINFO
Bongbong, family attend China embassy’s photo wall ribbon-cutting event
According to the new decision, people who received two Moderna shots initially and are 65 or older, over 18 and at high risk for Covid, or over 18 and have high occupational exposure, may now receive a booster.
All adults who received the one-shot J&J vaccine more than two months ago are also eligible for a booster.
Recommended videosPowered by AnyClip1/7WATCH: OCEAN PARK SA MANILA, BUKAS NA | CHONA YURead More
49.5K
9
Video Player is loading.Play VideoUnmuteDuration /Current Time Playback Speed Settings1xLoaded: 0%Remaining Time - FullscreenPlayUp NextThis is a modal window.Beginning of dialog window. Escape will cancel and close the window.TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaqueFont Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall CapsReset restore all settings to the default valuesDoneClose Modal DialogEnd of dialog window.Playback Speed0.25x0.5x1x Normal1.5x2xReplay the listPowered by AnyClip Privacy Policy
TOP ARTICLES
WATCH: OCEAN PARK SA MANILA, BUKAS NA | CHONA YU
NOW PLAYING
UP NEXT
WATCH: MGA MAGSASAKA, UMAARAY NA SA SMUGGLING NG GULAY NA GALING CHINA | CHONA YU
NOW PLAYING
UP NEXT
WATCH: MGA MAGSASAKA, SUMUGOD SA MENDIOLA | CHONA YU
NOW PLAYING
UP NEXT
Atienza: Makabayan endorses Pacquiao
NOW PLAYING
UP NEXT
Bongbong pressed by Atienza to apologize not revise martial law's dark history
NOW PLAYING
UP NEXT
Palace believes medical graduates, board passers to suffice resigning health workers
NOW PLAYING
UP NEXT
Duterte admin ‘not soft’ on cops as cases will be filed to those linked in drug war cases —Roque
NOW PLAYING
UP NEXT
WATCH: OCEAN PARK SA MANILA, BUKAS NA | CHONA YU
Previously, only immune-compromised people or people who belonged to elderly or high-risk groups and had received the Pfizer vaccine initially were eligible for a boost.
The data supporting the decisions come from emerging research reviewed by the FDA.
“Today’s actions demonstrate our commitment to public health in proactively fighting against the Covid-19 pandemic,” said acting FDA commissioner Janet Woodcock.
The statement also cautioned of highly rare side effects associated with the vaccines.
The messenger RNA vaccines, Pfizer and Moderna, have been associated with increased risks of inflammatory heart conditions, myocarditis, and pericarditis, especially in younger males.
The J&J vaccine has been linked to a serious and rare type of blood clot in combination with low blood platelets one or two weeks after administration. The risk is highest among females ages 18 through 49 years.
/MUF
.inline_ffff input { width: 70%!important; }
.bypro {
float: right;
width: 71%;
text-align: center;
margin-top: -12px;
margin-right: 15px;
clear: both;
color: #5C5C5C;
font-size: 8px!important;
line-height: 9px!important;
}
.lfform-inquirer-horizontal h2 {
font-weight: bold !important;
font-family: mallory !important;
}
@media only screen and (min-width: 360px) and (max-width: 767px) {
.lfform-inquirer-horizontal #myForm3 {
width: 100%;
display: flex;
flex-wrap: wrap;
justify-content: center;
}
.lfform-inquirer img {
width: 100% !important;
margin: 0 !important;
}
.bypro {
margin-top: 10px;
}
.lfform-inquirer-horizontal input[type=""email""] {
width: 100% !important;
}
.lfform-inquirer-horizontal input[type=""submit""], .lfform-inquirer-horizontal input[type=""button""] {
width: 100% !important;
}
}
.formv4 {
width: 100%!important;
max-width: 100%;
margin: 15px 0;
}
.formv4 input[type=""email""] {
font-weight: bold;
float: left;
-webkit-appearance: none;
margin: 0!important;
width: 70% !important;
}
.formv4 input[type=""submit""] {
font-weight: bold;
width: 28% !important;
padding: 3%;
float: left;
-webkit-appearance: none;
}
.formv4 #myForm3 {
width: 100%;
display: flex;
flex-wrap: wrap;
justify-content: space-between;
}
.formv4 .bypro {
width:100%;
font-family: 'noto serif';
float: unset;
clear: both;
color: #333333;
font-size: 11px!important;
line-height: 1 !important;
margin: 10px 3px;
text-align:left;
}
.formv4 a, .formv4 a:visited, .formv4 a:hover {
color: #0b72b5 !important;
text-decoration: none; !important;
}
.formv4 h2 {
font-weight: bold !important;
text-align: left;
font-family: mallory !important;
color: #333333 !important;
margin:5px 0 !important;
padding: 0 !important;
}
.formv4 p {
width: 100%;
text-align: left;
color: #5A5A5A !important;
font-family: 'noto serif' !important;
font-size: 14px !important;
margin: 0 !important;
line-height: 1.6em !important;
margin-bottom: 15px !important;
padding: 0 !important;
}
@media only screen and (min-width: 360px) and (max-width: 767px) {
.formv4 h2 {
font-size: 16px !important;
}
.formv4 .bypro {
font-size: 12px!important;
margin: 5px 5px;
}
.formv4 input[type=""email""] {
width: 100% !important;
}
.formv4 input[type=""submit""] {
width: 100% !important;
margin: 10px 0;
}
.formv4 {
width: 95%!important;
max-width: 95%;
margin: 20px auto;
}
}
Subscribe to our daily newsletter
By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.
#inqplus-article2 {
width: 100%;
height: 250px;
margin: 20px auto;
background-color: #a5b8c5;
display: flex;
flex-wrap: wrap;
justify-content: space-between;
align-items: flex-start;
}
#inqplus-cta-wrap {
width: 50%;
height: 250px;
background-image: url(/single2017/images/inqplus-sub/inqplus-cta-bg1.png);
background-repeat: no-repeat;
background-size: cover;
}
#inqplus-cta2 {
width: 89%;
height: auto;
margin: 35px auto 0;
}
#inqplus-cta2 img {
width: 100%;
}
#newsletter-cta-wrap {
width: 50%;
height: 250px;
background-image: url(/single2017/images/inqplus-sub/newsletter-bg1.png);
position: relative;
background-repeat: no-repeat;
background-size: cover;
}
#newsletter-cta2 {
width: 95%;
position: absolute;
bottom: -4px;
z-index: 1;
}
#newsletter-cta2 img {
width: 100%;
}
#inqplus-nl-sub2 {
width: 65%!important;
display: flex;
font-size: 0;
box-sizing: border-box;
z-index: 2;
position: absolute;
bottom: 10px;
right: 10px;
}
#inqplus-nl-sub2 form {
width: 100%!important;
}
.sub-input2 {
width: 70%!important;
height: 25px!important;
border: 0!important;
padding: 5px 0 5px 10px!important;
margin: 0!important;
box-sizing: border-box!important;
border-radius:0;
-webkit-appearance:none;
}
.sub-btn2 {
width: 30%!important;
height: 25px!important;
border: 0!important;
padding: 0!important;
margin: 0!important;
background-color: #004a87!important;
color: #f5f5f5!important;
text-transform: uppercase!important;
border-radius:0;
-webkit-appearance:none;
}
/* 414px */
@media only screen and (min-width: 414px) and (max-width: 599px){
#inqplus-article2 {
width: 98%;
height: auto;
}
#inqplus-cta-wrap {
width: 100%;
height: auto;
}
#newsletter-cta-wrap {
width: 100%;
}
#newsletter-cta2 img {
width: 90%;
}
}
/* 320px */
@media only screen and (min-width: 320px) and (max-width: 413px){
#inqplus-article2 {
width: 98%;
height: auto;
}
#inqplus-cta-wrap {
width: 100%;
}
#newsletter-cta-wrap {
width: 100%;
}
}
Read Next
Drilon: Tax and then ban Chinese firm in pandemic funds mess
VerrulonRemove Warts & Skin Tags Safely At Home! Try Out Now!Verrulon|SponsoredSponsoredUndoWork from Home | Search AdsDo You Speak English? Work a USA job from home in PhilippinesWork from Home | Search Ads|SponsoredSponsoredUndoDatemyage.comPhilippines Singles Age 40+ Are Finding Love With This Dating Site!Visit and check out 100% verified profiles nearbyDatemyage.com|SponsoredSponsoredUndoPerfect-Dating.comAgusan Del Norte is actually full of single handsome guys. Check them out on this free dating sitePerfect-Dating.com|SponsoredSponsoredUndoArticles SkillDean Martin's Daughter Finally Confirms the RumorsArticles Skill|SponsoredSponsoredUndoUnsold Cars | Search adsPrices of Unsold New Cars In Butuan Could Greatly Surprise YouUnsold Cars | Search ads|SponsoredSponsoredUndoDatemyage.comAre you 40+ and single?Meet senior singles just near you in ${city:capitalized}$Datemyage.com|SponsoredSponsoredUndo
window._taboola = window._taboola || [];
_taboola.push({
mode: 'thumbnails-d',
container: 'taboola-below-article-thumbnails-desktop',
placement: 'Below Article Thumbnails - newsinfo',
target_type: 'mix'
});
window._taboola = window._taboola || [];
_taboola.push({
mode: 'thumbnails-e',
container: 'taboola-below-article-thumbnails-mobile',
placement: 'Below Article Thumbnails - newsinfo',
target_type: 'mix'
});
EDITORS' PICK
Leaked: A 60x Zoom and all-new Helio G96 mean a complete overhaul for TECNO Mobile’s new CAMON 18 series
US FDA clears Moderna, J&J COVID-19 boosters, backs use of different vaccine for boost
Pagasa: Fair weather on Thursday; cooler days coming
Next level mobile photography within reach with vivo X70 co-engineered with ZEISS
DOJ drug war review: Killer cops had it easy
Delivering delight against all odds
MOST READ
Drilon: Tax and then ban Chinese firm in pandemic funds mess
‘Saving’ Manila Bay: Dolomite beach, wetlands drowning in wastes
US FDA clears Moderna, J&J COVID-19 boosters, backs use of different vaccine for boost
Villar scolds DENR over ‘scant’ funding proposal for protected areas
Don't miss out on the latest news and information.
View comments" - https://www.affordablecebu.com/
